Inventor
SIEGEL MATTHEW
US22 patents
⚠️ This page may combine multiple inventors who share the name “SIEGEL MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LIVE NATION ENTERTAINMENT INC
10 patentsUS9740988B1Aug 22, 2017
System and method for using unique device indentifiers to enhance security
LIVE NATION ENTERTAINMENT INC233 citations98
US9686241B1Jun 20, 2017
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC11 citations92
US9477820B2Oct 25, 2016
Systems and methods for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC19 citations92
US10102393B2Oct 16, 2018
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC3 citations83
US9978023B2May 22, 2018
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC10 citations83
US11734442B2Aug 22, 2023
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC2 citations72
US11593501B2Feb 28, 2023
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC1 citations72
US10878118B2Dec 29, 2020
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC1 citations72
US10402580B2Sep 3, 2019
System and method for using unique device identifiers to enhance security
LIVE NATION ENTERTAINMENT INC2 citations72
US11373151B2Jun 28, 2022
Apparatus for access control and processing
LIVE NATION ENTERTAINMENT INC0 citations62
ANWITA BIOSCIENCES INC
7 patentsUS12240879B2Mar 4, 2025
Interleukin-22 fusion proteins, and their pharmaceutical compositions
ANWITA BIOSCIENCES INC2 citations73
US12215130B2Feb 4, 2025
Cytokine-albumin binding moiety fusion proteins and uses thereof
ANWITA BIOSCIENCES INC2 citations72
US11692020B2Jul 4, 2023
Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applications
ANWITA BIOSCIENCES INC2 citations71
US12398188B2Aug 26, 2025
Cytokine fusion proteins, and their pharmaceutical compositions and therapeutic applications
ANWITA BIOSCIENCES INC0 citations61
US12091438B2Sep 17, 2024
Anti-mesothelin constructs and uses thereof
ANWITA BIOSCIENCES INC0 citations61
US12479909B2Nov 25, 2025
Albumin binding antibodies and use thereof
ANWITA BIOSCIENCES INC0 citations59
US11897930B2Feb 13, 2024
Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
ANWITA BIOSCIENCES INC0 citations59
ARDELYX INC
4 patentsUS10968246B2Apr 6, 2021
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
ARDELYX INC2 citations71
US10392413B2Aug 27, 2019
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
ARDELYX INC3 citations71
US10376481B2Aug 13, 2019
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
ARDELYX INC3 citations71
US12084472B2Sep 10, 2024
Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
ARDELYX INC0 citations50